When should children with HIV infection be started on antiretroviral therapy?

<h4>Background to the debate</h4>The advent of highly active antiretroviral therapy (HAART) dramatically improved the prognosis for both adults and children infected with HIV who had access to treatment. However, the optimal timing for initiating treatment remains controversial, particul...

Full description

Saved in:
Bibliographic Details
Main Authors: Steven B Welch, Di Gibb
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2008-03-01
Series:PLoS Medicine
Online Access:https://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.0050073&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850240690246647808
author Steven B Welch
Di Gibb
author_facet Steven B Welch
Di Gibb
author_sort Steven B Welch
collection DOAJ
description <h4>Background to the debate</h4>The advent of highly active antiretroviral therapy (HAART) dramatically improved the prognosis for both adults and children infected with HIV who had access to treatment. However, the optimal timing for initiating treatment remains controversial, particularly in children. This debate lays out the case for deferred treatment against the case for early initiation of HAART in children.
format Article
id doaj-art-c61397ee7a2a4ab18361f421a5c8c348
institution OA Journals
issn 1549-1277
1549-1676
language English
publishDate 2008-03-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Medicine
spelling doaj-art-c61397ee7a2a4ab18361f421a5c8c3482025-08-20T02:00:47ZengPublic Library of Science (PLoS)PLoS Medicine1549-12771549-16762008-03-0153e7310.1371/journal.pmed.0050073When should children with HIV infection be started on antiretroviral therapy?Steven B WelchDi Gibb<h4>Background to the debate</h4>The advent of highly active antiretroviral therapy (HAART) dramatically improved the prognosis for both adults and children infected with HIV who had access to treatment. However, the optimal timing for initiating treatment remains controversial, particularly in children. This debate lays out the case for deferred treatment against the case for early initiation of HAART in children.https://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.0050073&type=printable
spellingShingle Steven B Welch
Di Gibb
When should children with HIV infection be started on antiretroviral therapy?
PLoS Medicine
title When should children with HIV infection be started on antiretroviral therapy?
title_full When should children with HIV infection be started on antiretroviral therapy?
title_fullStr When should children with HIV infection be started on antiretroviral therapy?
title_full_unstemmed When should children with HIV infection be started on antiretroviral therapy?
title_short When should children with HIV infection be started on antiretroviral therapy?
title_sort when should children with hiv infection be started on antiretroviral therapy
url https://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.0050073&type=printable
work_keys_str_mv AT stevenbwelch whenshouldchildrenwithhivinfectionbestartedonantiretroviraltherapy
AT digibb whenshouldchildrenwithhivinfectionbestartedonantiretroviraltherapy